Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
September 4, 2025
Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease
Garrett R Mullins, Paul Ardayfio, Ivelina Gueorguieva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2017
Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent
Bangwen Xie, Michal R Tomaszewski, André A Neves, et al.
Cancer Discovery
|
April 6, 2013
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
Charli L Dominguez, Desiree H Floyd, Aizhen Xiao, et al.
Cancer Biology & Therapy
|
November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer
Kalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
The British Journal of Social Psychology
|
July 23, 2025
The 'twin pandemics'? modelling and predicting the trajectories of IPV perpetration during the COVID-19 pandemic in Australia
Gery C Karantzas, Daniel A Romano, Susan Chesterman, et al.
Journal of Paediatrics and Child Health
|
December 1, 2004
ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres
K Baumgart, S Brown, M Gold, et al.
Human Molecular Genetics
|
January 12, 2001
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor
N Jacobson, M Andrews, A R Shepard, et al.
The Journal of Clinical Investigation
|
March 2, 2016
Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation
Samantha E Adamson, Rachael Griffiths, Radim Moravec, et al.
Journal for Immunotherapy of Cancer
|
September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Stefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 10, 2026
Infusion-related reactions in donanemab-treated participants with early symptomatic Alzheimer's disease
Paul Ardayfio, Garrett R Mullins, Rashna Khanna, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Alzheimer'S & Dementia (New York, N. Y.)
|
September 4, 2025
Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease
Garrett R Mullins, Paul Ardayfio, Ivelina Gueorguieva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2017
Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent
Bangwen Xie, Michal R Tomaszewski, André A Neves, et al.
Cancer Discovery
|
April 6, 2013
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
Charli L Dominguez, Desiree H Floyd, Aizhen Xiao, et al.
Cancer Biology & Therapy
|
November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer
Kalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
The British Journal of Social Psychology
|
July 23, 2025
The 'twin pandemics'? modelling and predicting the trajectories of IPV perpetration during the COVID-19 pandemic in Australia
Gery C Karantzas, Daniel A Romano, Susan Chesterman, et al.
Journal of Paediatrics and Child Health
|
December 1, 2004
ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres
K Baumgart, S Brown, M Gold, et al.
Human Molecular Genetics
|
January 12, 2001
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor
N Jacobson, M Andrews, A R Shepard, et al.
The Journal of Clinical Investigation
|
March 2, 2016
Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation
Samantha E Adamson, Rachael Griffiths, Radim Moravec, et al.
Journal for Immunotherapy of Cancer
|
September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Stefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 10, 2026
Infusion-related reactions in donanemab-treated participants with early symptomatic Alzheimer's disease
Paul Ardayfio, Garrett R Mullins, Rashna Khanna, et al.
Page
of 19